Apr. 5, 2012 | Allgemein, company news @en, DE
The hospital operator Asklepios published its preliminary business result of 2011 on Wednesday. Accordingly, Germany’s largest hospital operator increased its turnover by around twelve percent to 2.557 billion Euro. The company stated that two-thirds of this...
März 20, 2012 | Allgemein, company news @en, DE
Strong business figures for 2011 are responsible for an upswing for Evotec, the biotech company from Hamburg, in premarket trade on Tuesday. The securities at brokers Lang & Schwarz rose by 3.62 percent to 2.86 Euro at 8.55 am, whereas the total market is...
März 20, 2012 | Allgemein, company news @en, DE
As part of the new Pharmacy Code (ApBetrO), the states want clear definitions of what constitutes an infringement in the production of blister packs and parenterals. As a basic principle, any pharmacy who produces blister packs for individual patients has to have a...
März 16, 2012 | Allgemein, company news @en, DE
In connection with the future Patients‘ Rights Law, Barmer GEK is demanding set criteria to ensure dependable patient information. The health fund expects the federal government to improve the transfer of evidence-based patient information to the people...
März 16, 2012 | Allgemein, company news @en, DE, market knowledge
The statutory health insurance (GKV) is financed by social security contributions and a tax subsidy. To keep the GKV contribution rate stable at 16 percent until 2060, tax subsidies of about 3.4 billion Euro would have to be paid until 2060. Without tax money, the GKV...
März 16, 2012 | Allgemein, company news @en, DE, transactions
Several heavy weights in the pharmaceutical industry are interested in the Turkish pharmaceutical company Mustafa Nevzat. Among them is the Germany health group Fresenius, who, along with GlaxoSmithKline from the UK and Pfizer and Merck & Co from the USA, has...
